These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10601885)

  • 21. [Cytokine-induced metallothionein expression and modulation of cytokine expression by metallothionein].
    Itoh N; Kimura T
    Yakugaku Zasshi; 2007 Apr; 127(4):685-94. PubMed ID: 17409698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical localization of metallothionein and its relation to doxorubicin toxicity in transgenic mouse heart.
    Zhou Z; Kang YJ
    Am J Pathol; 2000 May; 156(5):1653-62. PubMed ID: 10793076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity.
    Jing L; Wu Y; Wu J; Zhao J; Zuo D; Peng S
    Eur J Pharmacol; 2011 Jun; 659(2-3):224-32. PubMed ID: 21463615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant effect of zinc and zinc-metallothionein in the acute cytotoxicity of hydrogen peroxide in Ehrlich ascites tumour cells.
    Suntres ZE; Lui EMK
    Chem Biol Interact; 2006 Jul; 162(1):11-23. PubMed ID: 16730687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metallothionein 2A induction by zinc protects HEPG2 cells against CYP2E1-dependent toxicity.
    Pérez MJ; Cederbaum AI
    Free Radic Biol Med; 2003 Feb; 34(4):443-55. PubMed ID: 12566070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant defense against anthracycline cardiotoxicity by metallothionein.
    Kang YJ
    Cardiovasc Toxicol; 2007; 7(2):95-100. PubMed ID: 17652812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic cardiomyopathy and its prevention by metallothionein: experimental evidence, possible mechanisms and clinical implications.
    Cai L
    Curr Med Chem; 2007; 14(20):2193-203. PubMed ID: 17691957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Protective stress responsive protein: metallothionein].
    Kondoh M; Sato M
    Nihon Eiseigaku Zasshi; 2002 Jan; 56(4):634-40. PubMed ID: 11868393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
    Wu HY; Kang YJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant status in the liver of hypertensive and metallothionein-deficient mice.
    Bobillier-Chaumont S; Nicod L; Richert L; Berthelot A
    Can J Physiol Pharmacol; 2003 Oct; 81(10):929-36. PubMed ID: 14608409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant and antiapoptotic function of metallothioneins in HL-60 cells challenged with copper nitrilotriacetate.
    Kawai K; Liu SX; Tyurin VA; Tyurina YY; Borisenko GG; Jiang JF; St Croix CM; Fabisiak JP; Pitt BR; Kagan VE
    Chem Res Toxicol; 2000 Dec; 13(12):1275-86. PubMed ID: 11123969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAK2/STAT3 Pathway Mediates Protection of Metallothionein Against Doxorubicin-Induced Cytotoxicity in Mouse Cardiomyocytes.
    Rong J; Li L; Jing L; Fang H; Peng S
    Int J Toxicol; 2016 May; 35(3):317-26. PubMed ID: 26526549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals.
    Sato M; Kondoh M
    Tohoku J Exp Med; 2002 Jan; 196(1):9-22. PubMed ID: 12498322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of metallothionein reduces diabetic cardiomyopathy.
    Liang Q; Carlson EC; Donthi RV; Kralik PM; Shen X; Epstein PN
    Diabetes; 2002 Jan; 51(1):174-81. PubMed ID: 11756338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of zinc-metallothionein (Zn-MT) in iron nitrilotriacetate (Fe-NTA)-induced renal oxidative damage.
    Iqbal M; Noor R; Mizuno R; Okada S
    Redox Rep; 2003; 8(3):163-7. PubMed ID: 12935314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocyte cultures from transgenic mice to study the role of metallothionein in cytotoxicity of tert-butyl hydroperoxide.
    Suzuki Y; Apostolova MD; Cherian MG
    Toxicology; 2000 Apr; 145(1):51-62. PubMed ID: 10771131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metallothionein Preserves Akt2 Activity and Cardiac Function via Inhibiting TRB3 in Diabetic Hearts.
    Gu J; Yan X; Dai X; Wang Y; Lin Q; Xiao J; Zhou S; Zhang J; Wang K; Zeng J; Xin Y; Barati MT; Zhang C; Bai Y; Li Y; Epstein PN; Wintergerst KA; Li X; Tan Y; Cai L
    Diabetes; 2018 Mar; 67(3):507-517. PubMed ID: 29079702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiological significance of metallothionein in oxidative stress].
    Min KS
    Yakugaku Zasshi; 2007 Apr; 127(4):695-702. PubMed ID: 17409699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant role of metallothioneins: a comparative overview.
    Viarengo A; Burlando B; Ceratto N; Panfoli I
    Cell Mol Biol (Noisy-le-grand); 2000 Mar; 46(2):407-17. PubMed ID: 10774929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.